MSC-1186

• CAT Number: I042366
• CAS Number: 2871698-23-4
• Molecular Formula: C19H17ClFN7O2S
• Molecular Weight: 461.90
• Purity: ≥95%
• Synonyms: N-[3-[[[2-(5-chloro-4-fluoro-1H-benzimidazol-2-yl)pyrimidin-4-yl]amino]methyl]pyridin-2-yl]-N-methylmethanesulfonamide
• InChI: InChI=1S/C19H17ClFN7O2S/c1-28(31(2,29)30)19-11(4-3-8-23-19)10-24-14-7-9-22-17(26-14)18-25-13-6-5-12(20)15(21)16(13)27-18/h3-9H,10H2,1-2H3,(H,25,27)(H,22,24,26)
• InChIKey: WBFJDKLBAAHKIL-UHFFFAOYSA-N
• SMILES: CN(C1=C(C=CC=N1)CNC2=NC(=NC=C2)C3=NC4=C(N3)C=CC(=C4F)Cl)S(=O)(=O)C

MSC-1186（Cat No.:I042366）is a small molecule compound under investigation for its potential therapeutic applications, particularly in cancer treatment. It functions by targeting specific pathways involved in cell proliferation and survival, particularly in tumor cells. MSC-1186 exhibits inhibitory effects on key enzymes or receptors that contribute to the growth and spread of cancerous cells. This molecule is being explored in preclinical studies for its ability to induce apoptosis in cancer cells and overcome drug resistance mechanisms. Its promising pharmacological profile could lead to its development as a novel cancer therapy in the future.